Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.19
-0.0500-1.54%
Post-market: 3.220.0300+0.94%19:39 EDT
Volume:14.77M
Turnover:47.85M
Market Cap:1.71B
PE:-3.12
High:3.31
Open:3.26
Low:3.16
Close:3.24
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:1.19
T/O Rate:2.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:1.87
PE(LYR):-2.21

Loading ...

Aug 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jun 27, 2024

Proposed Sale Of Securities

Form144 | Recursion Pharmaceuticals' Officer Tina Marriott proposes to sell 6000 Shares, with a total value of approximately $43290.
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Proposed Sale Of Securities

Form144|Recursion Pharmaceuticals' Director Blake Borgeson proposes to sell 11447 Shares, with a total value of approximately $1.09 Million.
Jun 24, 2024

Major Issues Report

Form 8-K - Current report